Utah Innovation Fund is pleased to announce its recent investment in Purgo Scientific, a De Novo biotech firm with a mission to revolutionize treatment of surgical site infections. The Salt Lake City-based startup is Utah Innovation Fund’s seventh investment to date out of its $30M state-backed fund.

“What’s unique about Purgo is their focus on biofilm-related infections,” said Stan Oaks, Senior Associate at Utah Innovation Fund. “Most available solutions for surgical site infections are designed to fight planktonic bacteria, but biofilm-related infections are the bigger killer,” he continued. “This is a huge pain point.”

To read the full article, click here.